A
Avadel Pharmaceuticals - ADR (AVDL)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Avadel Pharmaceuticals - ADR (AVDL)
Avadel Pharmaceuticals PLC is a biopharmaceutical company. The Company’s lead product candidate, FT218, is an investigational once-nightly formulation of sodium oxybate for the treatment of excessive daytime sleepiness (EDS), and cataplexy in narcole... Read more
- USD9.47
- USD9.67
- USD9.32
- USD17.51
- 29.30%
- 182M
- 1.36M
- 1.26M
- 840M
- 6.38
- -40.70%
- 32.80%
Stock News
5 hours ago
Orion S.A. (OEC) Q1 2025 Earnings Call Transcript
SeekingAlpha
6 hours ago
Invesco Growth And Income Fund Q1 2025 Commentary
SeekingAlpha
6 hours ago
Transocean Stock Is Dirt-Cheap Thanks To Trump's Tariffs
SeekingAlpha
6 hours ago
Zurich Insurance: Good Operating Performance Seems To Be Priced-In Following Q1 Sales Update
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
